BR112019003013A2 - métodos de processamento de um fluido incluindo uma proteína terapêutica recombinante e uso do mesmo - Google Patents
métodos de processamento de um fluido incluindo uma proteína terapêutica recombinante e uso do mesmoInfo
- Publication number
- BR112019003013A2 BR112019003013A2 BR112019003013-1A BR112019003013A BR112019003013A2 BR 112019003013 A2 BR112019003013 A2 BR 112019003013A2 BR 112019003013 A BR112019003013 A BR 112019003013A BR 112019003013 A2 BR112019003013 A2 BR 112019003013A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic protein
- methods
- processing
- recombinant therapeutic
- fluid including
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 229960000160 recombinant therapeutic protein Drugs 0.000 title abstract 2
- 238000001914 filtration Methods 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000010924 continuous production Methods 0.000 abstract 1
- 229940088679 drug related substance Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000003672 processing method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/58—Multistep processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/06—Submerged-type; Immersion type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/16—Diafiltration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
a presente invenção refere-se a métodos de processamento de um fluido que incluem o uso tanto de um sistema de circuito incluindo uma unidade de filtragem de fluxo tangencial (tff) quanto um sistema de circuito incluindo uma unidade de filtragem de vírus de fluxo tangencial (tfvf). são ainda fornecidos processos integrados e contínuos para a fabricação de uma substância de fármaco de proteína terapêutica que incluem uma etapa de processamento de um fluido incluindo a proteína terapêutica recombinante usando qualquer um dos métodos fornecidos aqui.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662375689P | 2016-08-16 | 2016-08-16 | |
US62/375,689 | 2016-08-16 | ||
PCT/US2017/046930 WO2018035116A1 (en) | 2016-08-16 | 2017-08-15 | Methods of processing a fluid including a recombinant therapeutic protein and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019003013A2 true BR112019003013A2 (pt) | 2019-05-14 |
Family
ID=59799450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019003013-1A BR112019003013A2 (pt) | 2016-08-16 | 2017-08-15 | métodos de processamento de um fluido incluindo uma proteína terapêutica recombinante e uso do mesmo |
Country Status (13)
Country | Link |
---|---|
US (2) | US10968252B2 (pt) |
EP (2) | EP3500589B1 (pt) |
JP (2) | JP7106523B2 (pt) |
KR (1) | KR102465761B1 (pt) |
CN (1) | CN109843906B (pt) |
AU (1) | AU2017313042A1 (pt) |
BR (1) | BR112019003013A2 (pt) |
CA (1) | CA3034092A1 (pt) |
MX (2) | MX2019001859A (pt) |
RU (2) | RU2021119421A (pt) |
SG (1) | SG11201901220XA (pt) |
TW (1) | TWI767930B (pt) |
WO (1) | WO2018035116A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10968252B2 (en) | 2016-08-16 | 2021-04-06 | Genzyme Corporation | Methods of processing a fluid including a recombinant therapeutic protein and use thereof |
DK3512616T4 (da) * | 2017-11-16 | 2022-09-19 | Chromacon Ag | Fremgangsmåde til at overvåge, evaluere og styre en cyklisk kromatografisk oprensningsproces |
TW202003832A (zh) * | 2018-05-04 | 2020-01-16 | 美商健臻公司 | 具有過濾系統的灌注式生物反應器 |
CN113784779A (zh) | 2019-03-11 | 2021-12-10 | 建新公司 | 切向病毒过滤 |
EP3947705A1 (en) * | 2019-04-03 | 2022-02-09 | Genzyme Corporation | Continuous production of recombinant proteins |
BR112022007525A2 (pt) | 2019-10-22 | 2022-07-12 | Genzyme Corp | Monitoramento de produto em linha na biofabricação contínua integrada |
KR20240039642A (ko) * | 2022-09-19 | 2024-03-27 | 주식회사 녹십자 | 신규 헤파란-n-설파타아제의 정제 방법 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH692479A5 (de) * | 1997-07-08 | 2002-07-15 | Bucher Guyer Ag | Querstrom-Filtrationsanlage sowie Verfahren zum Betrieb einer solchen Anlage. |
GB9821342D0 (en) | 1998-10-02 | 1998-11-25 | Common Services Agency | Device for treatment of biological fluids |
US6214221B1 (en) * | 1999-02-22 | 2001-04-10 | Henry B. Kopf | Method and apparatus for purification of biological substances |
US6296770B1 (en) * | 1999-12-09 | 2001-10-02 | Eastman Kodak Company | Constant concentration at the UF membrane wall UF process control and apparatus |
US6365395B1 (en) * | 2000-11-03 | 2002-04-02 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
DK1337280T3 (da) | 2000-11-13 | 2013-12-02 | Bayer Ip Gmbh | Fremgangsmåde til inaktivering af mikroorganismer i en fluid ved anvendelse af ultraviolet stråling |
WO2003102132A2 (en) * | 2002-04-26 | 2003-12-11 | Genetech, Inc. | Non-affinity purification of proteins |
US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
US7384549B2 (en) * | 2005-12-29 | 2008-06-10 | Spf Innovations, Llc | Method and apparatus for the filtration of biological solutions |
US20080017576A1 (en) * | 2006-06-15 | 2008-01-24 | Rensselaer Polytechnic Institute | Global model for optimizing crossflow microfiltration and ultrafiltration processes |
WO2008073620A2 (en) * | 2006-11-02 | 2008-06-19 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
US7988859B2 (en) | 2009-02-05 | 2011-08-02 | Chromatan Inc. | Countercurrent tangential chromatography methods, systems, and apparatus |
US20100237013A1 (en) * | 2009-02-13 | 2010-09-23 | Millipore Corporation | Autonomous filter element |
US8728479B2 (en) | 2009-03-31 | 2014-05-20 | The Trustees Of The University Of Pennsylvania | Antigen-binding proteins comprising recombinant protein scaffolds |
WO2011071676A1 (en) | 2009-12-11 | 2011-06-16 | Wyssmont Company Inc. | Apparatus and method for continuous lyophilization |
EP2914612B1 (en) | 2012-10-30 | 2018-11-14 | F.Hoffmann-La Roche Ag | Purification of polypeptides using dual stage tangential-flow ultrafiltration |
US10030063B2 (en) * | 2012-12-18 | 2018-07-24 | Novartis Ag | Production of therapeutic proteins in genetically modified mammalian cells |
RU2768003C2 (ru) * | 2013-03-08 | 2022-03-22 | Джензим Корпорейшн | Интегрированное непрерывное производство терапевтических белковых лекарственных веществ |
US10968252B2 (en) | 2016-08-16 | 2021-04-06 | Genzyme Corporation | Methods of processing a fluid including a recombinant therapeutic protein and use thereof |
-
2017
- 2017-08-15 US US15/677,888 patent/US10968252B2/en active Active
- 2017-08-15 EP EP17762255.2A patent/EP3500589B1/en active Active
- 2017-08-15 MX MX2019001859A patent/MX2019001859A/es unknown
- 2017-08-15 AU AU2017313042A patent/AU2017313042A1/en active Pending
- 2017-08-15 KR KR1020197007518A patent/KR102465761B1/ko active IP Right Grant
- 2017-08-15 TW TW106127646A patent/TWI767930B/zh active
- 2017-08-15 SG SG11201901220XA patent/SG11201901220XA/en unknown
- 2017-08-15 CN CN201780063527.0A patent/CN109843906B/zh active Active
- 2017-08-15 WO PCT/US2017/046930 patent/WO2018035116A1/en unknown
- 2017-08-15 RU RU2021119421A patent/RU2021119421A/ru unknown
- 2017-08-15 BR BR112019003013-1A patent/BR112019003013A2/pt unknown
- 2017-08-15 EP EP21193609.1A patent/EP3950702A1/en active Pending
- 2017-08-15 CA CA3034092A patent/CA3034092A1/en active Pending
- 2017-08-15 JP JP2019508971A patent/JP7106523B2/ja active Active
- 2017-08-15 RU RU2019107142A patent/RU2751506C2/ru active
-
2019
- 2019-02-14 MX MX2021015165A patent/MX2021015165A/es unknown
-
2021
- 2021-02-19 US US17/180,272 patent/US11884703B2/en active Active
-
2022
- 2022-05-20 JP JP2022082749A patent/JP2022110128A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022110128A (ja) | 2022-07-28 |
SG11201901220XA (en) | 2019-03-28 |
CN109843906A (zh) | 2019-06-04 |
CA3034092A1 (en) | 2018-02-22 |
US20210171572A1 (en) | 2021-06-10 |
US10968252B2 (en) | 2021-04-06 |
US20180051054A1 (en) | 2018-02-22 |
MX2021015165A (es) | 2022-01-18 |
EP3500589A1 (en) | 2019-06-26 |
MX2019001859A (es) | 2019-08-29 |
JP7106523B2 (ja) | 2022-07-26 |
CN109843906B (zh) | 2023-09-01 |
EP3950702A1 (en) | 2022-02-09 |
RU2021119421A (ru) | 2021-07-13 |
KR20190046872A (ko) | 2019-05-07 |
RU2751506C2 (ru) | 2021-07-14 |
TWI767930B (zh) | 2022-06-21 |
US11884703B2 (en) | 2024-01-30 |
KR102465761B1 (ko) | 2022-11-09 |
RU2019107142A (ru) | 2020-09-18 |
WO2018035116A1 (en) | 2018-02-22 |
AU2017313042A1 (en) | 2019-04-04 |
JP2019532916A (ja) | 2019-11-14 |
EP3500589B1 (en) | 2022-05-04 |
RU2019107142A3 (pt) | 2020-12-17 |
TW201811816A (zh) | 2018-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112019003013A2 (pt) | métodos de processamento de um fluido incluindo uma proteína terapêutica recombinante e uso do mesmo | |
DK3597646T3 (da) | Terapeutiske forbindelser egnede til den profylaktiske eller terapeutiske behandling af en hiv-virusinfektion | |
CL2017001798A1 (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas. | |
CL2020002043A1 (es) | Métodos y composiciones para la entrega de proteínas terapeuticas. | |
BR112019006887A2 (pt) | ativadores do fluxo autofágico e fosfolipase d e depuração de agregado proteico, incluindo tau e tratamento de proteinopatias | |
CO2018007203A2 (es) | Focalización de péptidos para dirigir virus adenoasociados (aavs) | |
SG11201606154UA (en) | System and method for assuring patient medication and fluid delivery at the clinical point of use | |
CL2015003655A1 (es) | Polipéptidos f de prefusión del virus sincicial respiratorio (rsv) solubles y estabilizados | |
CL2018002826A1 (es) | Proteínas f de prefusión del virus respiratorio sincicial (vrs) solubles y estabilizadas | |
BR112016029848A2 (pt) | proteínas de fusão mic-1 e utilizações das mesmas | |
BR112016025819A2 (pt) | vetores de vírus adeno-associados para o tratamento de doenças de depósito lisossômico | |
CL2015000784A1 (es) | Compuestos derivados de acilaminopirimidina, inductores de interferon; composicion farmaceutica que los comprende; su uso en el tratamiento de infecciones viricas, trastornos inmunitarios, cancer y otras enfermedades. | |
BR112015028119A2 (pt) | dispositivo filtrante de ar | |
BR112017020735A2 (pt) | sistema de tratamento com inicialização por pressão de aparelho de infusão | |
CL2020001253A1 (es) | Sistema para monitorizar pacientes que padecen de enfermedad respiratoria que comprende un dispositivo médico portátil y método basado en el uso de este sistema | |
DK3759083T3 (da) | 2,4-diaminoquinazolinderivater og anvendelse deraf til behandling af virusinfektioner, cancer eller allergier | |
MA49393A (fr) | Poly(phosphoesters) destinés à l'administration d'acides nucléiques | |
BR112016021535A8 (pt) | kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso | |
DE112017000667A5 (de) | Auslassgraft sowie system umfassend eine blutpumpe und einen auslassgraft | |
KR102006908B9 (ko) | 전기 삼투 펌프 및 이를 포함하는 유체 펌핑 시스템 | |
Delgado et al. | Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia | |
MA42964A (fr) | Préparation pharmaceutique anti-vieillissement | |
SG10201800760UA (en) | System and method for assuring patient medication and fluid delivery at the clinical point of use | |
DK3538134T3 (da) | Trunkeret von willebrand-faktor polypeptider til ekstravaskulær administration til behandling eller profylakse af en blodkoagulationsforstyrrelse | |
DE112018006114A5 (de) | Kanüle, kanülensystem und blutpumpensystem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |